Stingraytx
Houston, US · Founded 2018 · 1 known investors
Find your way into Stingraytx
28 people in our graph share verified history with the Stingraytx team — schools, employers, funds. One of them is your warm intro.
Massimo Prelzunlockedknows Jonathan P. Northrup · together at The Wharton School (overlapped)
×5knows the team · via The Wharton School
×6knows the team · via Northwestern University
Stingray is an oncology-focused biotech company developing drugs from discovery through clinical development to commercialization, led by scientists and physicians with experience in building oncology companies.
Founders & leadership
Stingraytx was founded in 2018 by Jonathan Northrup and Sunil Sharma.
JN
Jonathan NorthrupinChief Executive Officer, Co-FounderJonathan Northrup spent 28 years at Eli Lilly in roles spanning sales, marketing, business development, and corporate strategy before founding multiple biotech companies, including Salarius Pharmaceuticals (a public oncology company) and currently serving as CEO and co-founder of Stingray Therapeutics, an immune oncology-focused biotech developer.
SS
Sunil SharmainChief Medical Officer, Co-Founder
SA
Scott Andrew JordanNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.6M disclosed across 4 rounds · 2020–2024
▶$25KraisedMay 2024 · 1 investors · BiotechnologyRule 506(b)
▶$25KraisedMay 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan P. NorthrupExecutive Officer, Director
- Sunil SharmaExecutive Officer, Director
- Uma BhattExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $25K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$436.8KraisedFeb 2024 · 21 investors · BiotechnologyRule 506(b)
▶$436.8KraisedFeb 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Uma BhattExecutive Officer, Director
- Jonathan P. NorthrupExecutive Officer, Director
- Sunil SharmaExecutive Officer, Director
- Offering amount
- $450K
- Amount sold
- $436.8K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.6MraisedDec 2023 · 52 investors · BiotechnologyRule 506(b)
▶$6.6MraisedDec 2023 · 52 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan P. NorthrupExecutive Officer, Director
- Sunil SharmaExecutive Officer, Director
- Uma BhattExecutive Officer, Director
- Offering amount
- $6.7M
- Amount sold
- $6.6M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan P. NorthrupExecutive Officer, Director, Promoter
- Scott Andrew JordanExecutive Officer, Director, Promoter
- Sunil SharmaExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $1.5M
- Sales commissions
- $32.5K
- Finders' fees
- $29.5K
- Proceeds to insiders
- $32.5K
- Placement agents
- Liberi Life Sciences Consultancy BV, Finalis Securities LLC
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Stingraytx do?
- Stingray is an oncology-focused biotech company developing drugs from discovery through clinical development to commercialization, led by scientists and physicians with experience in building oncology companies.
- Who founded Stingraytx?
- Stingraytx was founded by Jonathan Northrup, Sunil Sharma in 2018.
- Who are Stingraytx's investors?
- Stingraytx's investors include Green Park & Golf Ventures.
- How much funding has Stingraytx raised?
- Stingraytx has disclosed $8.6M raised across 4 rounds.
- Where is Stingraytx headquartered?
- Stingraytx is headquartered in Houston, US.